AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2006
Sep 14, 2006
29777_dirs_2006-09-14_2c0a97f1-81ea-4866-9c5d-f2f0edef0240.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-07-31
Reporting Person: Fussell Stephen R (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-07-31 | Common shares without par value | F | 15825 | $47.82 | Disposed | 79897 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-07-31 | Option (right to buy) | $47.82 | A | 2885 | Acquired | 2010-02-10 | Common shares (2885) | Direct |
| 2006-07-31 | Option (right to buy) | $47.82 | A | 11636 | Acquired | 2013-02-13 | Common shares (11636) | Direct |
Footnotes
F1: Due to an administrative error, the number of shares previously reported as having been used to pay for his July 31 exercises and the number of shares granted as replacement options with respect to those exercises were incorrect. This Form 4 reports the correct numbers.
F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Earnings Release
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25